Balyasny Asset Management
TCRX icon

Balyasny Asset Management’s TScan Therapeutics TCRX Stock Holding History

Balyasny Asset Management’s Portfolio TCRX Stock Details TCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-41,942
Closed -$333K – 2406
2024
Q1 		$333K Sell
41,942
-4,044
-9% -$32.1K ﹤0.01% 1622
2023
Q4 		$268K Buy
+45,986
New +$268K ﹤0.01% 1651